CCL20 has been associated with poor prognosis in BC patients, Lee et al. reported that patients with high expression of CCL20 showed significantly lower overall survival and metastasis-free survival, in addition to increase cell invasion and secretion of MMP2 and MMP9 in TNBC cells (132). Here, CCL20 is linked to breast cancer.